These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 6494048)

  • 1. [Circulating platelet aggregates in various vascular diseases].
    Kotschy M; Zembala A
    Pol Tyg Lek; 1984 Jun 12-25; 39(25-26):875-7. PubMed ID: 6494048
    [No Abstract]   [Full Text] [Related]  

  • 2. [Blood viscosimetric factors in cardiovascular pathology].
    Caimi G; Catania A; Romano A; Francavilla G; La Bruzzo S; Sarno A
    Minerva Cardioangiol; 1980 Sep; 28(9):611-20. PubMed ID: 7465068
    [No Abstract]   [Full Text] [Related]  

  • 3. [Relations between parameters of lipid metabolism and hemostasis in vascular diseases].
    Frick G; Frick U; Brachmann K
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(4):511-8. PubMed ID: 6083921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The state of hemostasis in obliterating diseases of the vessels of the lower limbs].
    Andrukhova RV; Kushnir TI
    Lab Delo; 1991; (7):71-2. PubMed ID: 1724049
    [No Abstract]   [Full Text] [Related]  

  • 5. [Evaluation of the platelet component in chronic obliterating vascular disease of the lower limbs].
    Avellone G; Nova S; Gullotti D; Mandalà V
    Boll Soc Ital Cardiol; 1979; 24(2):135-41. PubMed ID: 548089
    [No Abstract]   [Full Text] [Related]  

  • 6. [Changes in systemic blood viscosity in subjects with regional chronic vasculopathies during spontaneous and induced ischemia].
    Di Perri T; Forconi S; Guerrini M; Rossi C; Pecchi S
    Boll Soc Ital Cardiol; 1977; 22(7):1138-50. PubMed ID: 618247
    [No Abstract]   [Full Text] [Related]  

  • 7. [Studies of circulating platelet aggregates, using the Wu-Hoak method, in normal subjects and patients with vascular diseases: evaluation of the experimental error].
    Antonelli M; Argentino C; Bernardi S; De Marinis M; Ferri GM; Gandolfo GM; Prencipe M
    Boll Soc Ital Biol Sper; 1978 May; 54(10):919-25. PubMed ID: 743399
    [No Abstract]   [Full Text] [Related]  

  • 8. [Platelet aggregation in obliterating arteriopathies of the lower limbs. Preliminary findings].
    Rossi M; Evangelisti L; Giusti C; Santoro G; Pentimone F; Camici M
    Minerva Cardioangiol; 1982 Jun; 30(6):329-33. PubMed ID: 7133421
    [No Abstract]   [Full Text] [Related]  

  • 9. Circulating platelet-leukocyte aggregates: a marker of microvascular injury in diabetic patients.
    Elalamy I; Chakroun T; Gerotziafas GT; Petropoulou A; Robert F; Karroum A; Elgrably F; Samama MM; Hatmi M
    Thromb Res; 2008; 121(6):843-8. PubMed ID: 17825880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Increased pre- and postoperative thrombocyte activity in vascular surgery patients].
    Reininger CB; Reininger AJ; Steckmeier B; Lasser R; Schweiberer L
    Vasa; 1994; 23(3):217-27. PubMed ID: 7975867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Induced platelet aggregation in patients with healthy vessels and patients with stage II chronic arterial occlusive disease].
    Staiger J; Gastmann U; Lehmann M; Keul J
    Vasa; 1986; 15(4):387-91. PubMed ID: 3799025
    [No Abstract]   [Full Text] [Related]  

  • 12. [Anti-platelet aggregation action and paradoxical effects of acetylsalicylic acid].
    Mocchi N; Sbalzarini G; Cantaluppi P
    Clin Ter; 1985 Jul; 114(1):37-41. PubMed ID: 4042578
    [No Abstract]   [Full Text] [Related]  

  • 13. [In vitro prostaglandin I2 synthesis in normal and pathologically-changed human leg veins].
    Feigl W; Sinzinger H; Santler R; Oppolzer R; Silberbauer K
    Vasa; 1986; 15(1):47-51. PubMed ID: 3515799
    [No Abstract]   [Full Text] [Related]  

  • 14. [Therapeutic activity of anti-platelet aggregation agents in arterial diseases].
    Delboy C; Jouve R; Escande M; Juhan I; Bouvenot G
    Sem Hop Ther; 1977 Nov; 53(9):431-40. PubMed ID: 341318
    [No Abstract]   [Full Text] [Related]  

  • 15. Circulating platelet aggregates in patients with coronary heart disease and lower limb ischaemia.
    Popadić M; Haracić M; Rezaković D; Pirnat L
    Vasa; 1985; 14(1):35-7. PubMed ID: 3976275
    [No Abstract]   [Full Text] [Related]  

  • 16. [Increased platelet aggregation in diabetic patients and its significance as risk factor for vascular diseases].
    Jäger W; Pietsch U; Krzywanek HJ; Breddin K
    Verh Dtsch Ges Inn Med; 1973; 79():1360-2. PubMed ID: 4790182
    [No Abstract]   [Full Text] [Related]  

  • 17. [Erythrocyte aggregation values. A measure of myocardial infarct risk factors and of vascular lesions].
    Ruhenstroth-Bauer G; Porz P; Boss N; Koenig-Erich S; Lehmacher W; Stamm D
    MMW Munch Med Wochenschr; 1983 Sep; 125(36):771-4. PubMed ID: 6415432
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effects on platelet functions].
    Jacobi E; Richter O; Krüskemper G
    Fortschr Med; 1979 Feb; 97(7):279-83. PubMed ID: 437658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Disorders of microcirculation in the lower limbs].
    Polianskiĭ BA
    Sov Med; 1975 May; (5):74-8. PubMed ID: 1145309
    [No Abstract]   [Full Text] [Related]  

  • 20. Platelet aggregation abnormalities in arterial occlusive diseases (AOD).
    Benner KU; Geeren M; Burstedde V; Everts B
    J Med; 1984; 15(1):23-34. PubMed ID: 6593403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.